A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

The bovine papillomavirus type 1 (BPV-1) exonic splicing suppressor (ESS) is juxtaposed immediately downstream of BPV-1 splicing enhancer 1 and negatively modulates selection of a suboptimal 3' splice site at nucleotide 3225. The present study demonstrates that this pyrimidine-rich ESS inhibits utilization of upstream 3' splice sites by blocking early steps in spliceosome assembly. Analysis of the proteins that bind to the ESS showed that the U-rich 5' region binds U2AF65 and polypyrimidine tract binding protein, the C-rich central part binds 35- and 54-55-kDa serine/arginine-rich (SR) proteins, and the AG-rich 3' end binds alternative splicing factor/splicing factor 2. Mutational and functional studies indicated that the most critical region of the ESS maps to the central C-rich core (GGCUCCCCC). This core sequence, along with additional nonspecific downstream nucleotides, is sufficient for partial suppression of spliceosome assembly and splicing of BPV-1 pre-mRNAs. The inhibition of splicing by the ESS can be partially relieved by excess purified HeLa SR proteins, suggesting that the ESS suppresses pre-mRNA splicing by interfering with normal bridging and recruitment activities of SR proteins.

[1]  Q. Sun,et al.  A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. , 1994, The Journal of biological chemistry.

[2]  T. Maniatis,et al.  Synergistic interactions between two distinct elements of a regulated splicing enhancer. , 1995, Genes & development.

[3]  J. G. Patton,et al.  Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. , 1991, Genes & development.

[4]  M. Ashiya,et al.  A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. , 1997, RNA.

[5]  G. Casari,et al.  A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. , 1994, Nucleic acids research.

[6]  P. Zamore,et al.  Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Pérez,et al.  Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo. , 1997, RNA.

[8]  J. Manley,et al.  Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. , 1995, RNA.

[9]  Phillip A. Sharp,et al.  Split genes and RNA splicing , 1994, Cell.

[10]  R. Breathnach,et al.  The exon sequence TAGG can inhibit splicing. , 1996, Nucleic acids research.

[11]  Y. Shimura,et al.  The role of exon sequences in splice site selection. , 1993, Genes & development.

[12]  M. Stanley,et al.  A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Breathnach,et al.  Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon , 1995, Molecular and cellular biology.

[14]  M. Rosenfeld,et al.  Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements , 1993, Molecular and cellular biology.

[15]  P. Sharp,et al.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs , 1986, Cell.

[16]  R. Gontarek,et al.  Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing , 1996, Molecular and cellular biology.

[17]  O. Uhlenbeck,et al.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. , 1987, Nucleic acids research.

[18]  H. Bourbon,et al.  Novel Drosophila melanogaster genes encoding RRM-type RNA-binding proteins identified by a degenerate PCR strategy. , 1995, Gene.

[19]  M B Roth,et al.  SR proteins: a conserved family of pre-mRNA splicing factors. , 1992, Genes & development.

[20]  Adrian R. Krainer,et al.  The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites , 1990, Cell.

[21]  A. Kornblihtt,et al.  A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. , 1993, Genes & development.

[22]  M. Roth,et al.  A conserved epitope on a subset of SR proteins defines a larger family of Pre-mRNA splicing factors , 1995, The Journal of cell biology.

[23]  J. Manley,et al.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro , 1990, Cell.

[24]  M. Rosenfeld,et al.  A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Garcia-Blanco,et al.  The spliceosome assembly pathway in mammalian extracts , 1992, Molecular and cellular biology.

[26]  T. Cooper,et al.  Identification of a new class of exonic splicing enhancers by in vivo selection , 1997, Molecular and cellular biology.

[27]  A. Staffa,et al.  Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1 , 1995, Molecular and cellular biology.

[28]  L. Donehower,et al.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production , 1997, Journal of virology.

[29]  J. Valcárcel,et al.  Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. , 1995, Science.

[30]  Michael R. Green,et al.  Interaction of U2AF65 RS Region with Pre-mRNA of Branch Point and Promotion Base Pairing with U2 snRNA , 1996, Science.

[31]  T. Maniatis,et al.  The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. , 1996, Genes & development.

[32]  B. Amendt,et al.  Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. , 1995, Molecular and cellular biology.

[33]  A. Zahler,et al.  A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer , 1995, Molecular and cellular biology.

[34]  A. Krainer,et al.  General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. , 1993, Genes & development.

[35]  J. Manley,et al.  Primary structure of the human splicing factor asf reveals similarities with drosophila regulators , 1991, Cell.

[36]  A. Krainer,et al.  Functional expression of cloned human splicing factor SF2: homology to rna-binding proteins, U1 70K, and drosophila splicing regulators , 1991, Cell.

[37]  Koji Kariya-city Aichi-pref. Tanaka,et al.  Polypurine sequences within a downstream exon function as a splicing enhancer , 1994, Molecular and cellular biology.

[38]  A. Staffa,et al.  Novel Exonic Elements That Modulate Splicing of the Human Fibronectin EDA Exon* , 1997, The Journal of Biological Chemistry.

[39]  Lung-Ji Chang,et al.  Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1 , 1994, Molecular and cellular biology.

[40]  C. Baker,et al.  Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor , 1996, Journal of virology.

[41]  H. Leffers,et al.  Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. , 1995, European journal of biochemistry.

[42]  T. Cooper,et al.  The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element , 1993, Molecular and cellular biology.

[43]  C. H. Lin,et al.  Regulation of alternative 3' splice site selection by constitutive splicing factors. , 1995, RNA.

[44]  G. Dreyfuss,et al.  hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. , 1992, Nucleic acids research.

[45]  C. Baker,et al.  Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers , 1997, Journal of virology.

[46]  J. Manley,et al.  Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. , 1998, Genes & development.

[47]  J. Manley,et al.  The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. , 1995, The EMBO journal.